T. Morel

发表论文 39 篇 · 总被引 1176 次 · h-index 15

代表论文

• Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohort (2019 · Journal of Neurology · 被引 202)
• Measuring what matters to rare disease patients – reflections on the work by the IRDiRC taskforce on patient-centered outcome measures (2017 · Orphanet Journal of Rare Diseases · 被引 160)
• SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials (2021 · BMJ Open · 被引 119)
• Challenges in Research and Health Technology Assessment of Rare Disease Technologies: Report of the ISPOR Rare Disease Special Interest Group. (2018 · Value in Health · 被引 107)
• Ethical Considerations for the Inclusion of Patient-Reported Outcomes in Clinical Research: The PRO Ethics Guidelines. (2022 · Journal of the American Medical Association (JAMA) · 被引 74)
• Patient Experience in Early-Stage Parkinson’s Disease: Using a Mixed Methods Analysis to Identify Which Concepts Are Cardinal for Clinical Trial Outcome Assessment (2022 · Neurological Therapeutics · 被引 29)